Relationship of fibrinogen levels and hemostatic abnormalities with organ damage in hypertension

Hypertension

Volumn 36, Issue 6, 2000, Pages 978-985

  Sechi, Leonardo A ^a,b   Zingaro, Laura ^a   Catena, Cristiana ^a   Casaccio, Daniele ^a   De Marchi, Sergio ^a  

^a UNIVERSITY OF UDINE   (Italy)

^b UNIVERSITY OF UDINE   (Italy)

Author keywords

Antithrombin III; Coagulation; Fibrin D dimer; Fibrinogen; Hypertension, essential; Prothrombin fragment 1+2

Indexed keywords

ANTITHROMBIN III; D DIMER; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PROTHROMBIN; TRIACYLGLYCEROL;

ADULT; AGED; AGING; ARTICLE; ATHEROSCLEROSIS; BLOOD CLOTTING; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; ESSENTIAL HYPERTENSION; FEMALE; FIBRINOGEN BLOOD LEVEL; HEMOSTASIS; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; RISK FACTOR; SMOKING;

EID: 0033673883     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.36.6.978     Document Type: Article

References (37)

1. Blood pressure, stroke and coronary heart disease, Part 1: Prolonged differences in blood pressure: Prospective observational studies corrected for the regression dilution bias
2. Recent observations on the role of hemostatic determinants in the development of atherothrombotic plaques
3. Hemostasis in normotensive and hypertensive men: Results of the PROCAM study. The prospective cardiovascular Munster study
4. Haemostasis factors in angina pectoris; relation to gender, age and acute phase reaction. Results of the ECAT angina pectoris study group
5. Haemostatic function and ischemic heart disease: Principal results of the Northwick Park Heart Study
6. Fibrinogen as a risk factor for stroke and myocardial infarction
7. Blood viscosity, fibrinogen and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh Artery Study
8. Plasma fibrinogen-a major coronary risk factor
9. Detection and relevance of cross linked fibrin derivatives in blood
10. Plasma concentrations of cross- linked fibrin degradation product (D-dimer) and the risk of future myocardial infarction among apparently healthy men
11. Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study
12. Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease
13. Does hypertension confer a hypercoagulable state? Virchow's triad revisited
14. The role of rheological and haemostatic factors in hypertension
15. Does hypertension confer a hypercoagulable state?
16. 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension
17. Standardization of methods of lipid determination according to WHO in the regional project of prevention of cardiovascular diseases in Friuli-Venezia Giulia
18. Determinants of plasma fibrinogen: Relation to body weight, waist-to-hip ratio, smoking, alcohol, age and sex: Results from the second MONICA Augsburg Survey 1989-90
19. Plasma fibrinogen levels and correlated in young adults
20. Blood coagulation, fibrinolytic, and inhibitory proteins in end-stage renal disease: Effect of hemodialysis
21. Insulin hypersecretion: A distinctive feature between essential and secondary hypertension
22. Association of lipoprotein(a) levels and apolipoprotein(a) size polymorphism with target-organ damage in arterial hypertension
23. Method for determination of functional (clottable) fibrinogen by the new family of ACL coagulometers
24. Determination of human prothrombin activation fragment 1+2 in plasma with an antibody against a synthetic peptide
25. An immunoassay for human D-dimer using monoclonal antibodies
26. Haemostasis balance disorders in patients with essential hypertension
27. Fibrinogen levels in normotensive and hypertensive men: A cross-sectional study
28. Relation of endothelium, thrombogenesis, and hemorheology in systemic hypertension to ethnicity and left ventricular hypertrophy
29. Association of blood pressure with fibrinolytic potential in the Framingham offspring population
30. Von Willebrand factor and soluble E-selectin in hypertension: Influence of treatment and value in predicting the progression of atherosclerosis
31. Fate of fibrinogen in human arterial intima
32. The effect of physiological levels of fibrinogen on platelet aggregation
33. Coagulation and inhibitory and fibrinolytic proteins in essential hypertension
34. Effects of medium-term antihypertensive therapy on haemostatic parameters in patients with essential hypertension
35. Prothrombin activation fragment assay
36. Detection of prethrombotic state due to procoagulant imbalance
37. Evidence of platelet activation in hypertension